Notice of Award of a Single-Source Cooperative Agreement To Fund the Ministerio de Salud de la República de Panamá (MINSA), 6557 [2022-02406]
Download as PDF
<![CDATA[
6557
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
School-level Administrator (e.g., principal).
NSCPS Wave 4 and 5 Questionnaire.
Total ...........................................
...........................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–02405 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Ministerio de Salud de la Repu´blica de
Panama´ (MINSA)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $10,000,000 for
Year 1 of funding to the Ministerio de
Salud de la Repu´blica de Panama´
{MINSA}. The award will contribute to
the achievement of 95–95–95 targets
(95% of HIV-positive individuals
knowing their status, 95% of those
receiving ART [Antiretroviral therapy],
and 95% of those achieving viral
suppression) in Panama by introducing
or scaling up high-impact HIV
prevention, testing, linkage, and
treatment models across the continuum
of care and strengthening HIV laboratory
and information systems. Funding
amounts for years 2–5 will be set at
continuation.
DATES: The period for this award will be
September 30, 2022 through September
29, 2027.
FOR FURTHER INFORMATION CONTACT: Lily
de Leon, Center for Global Health,
Centers for Disease Control and
Prevention, 18 Avenida 11–37, Zona 15,
VHIII, Telephone: 800–232–6348, Email:
izo0@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will include key
HIV prevention and diagnosis activities:
Index testing, differentiated service
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:50 Feb 03, 2022
Jkt 256001
Number of
responses per
respondent
Average hours
per response
Total response
burden
(hours)
600
2
45/60
900
........................
........................
........................
900
Number of
respondents
Type of respondent
modalities at key population testing
facilities, self-testing, Pre-Exposure
Prophylaxis (PreP), rapid recency
testing and response to clusters of recent
transmission, and linkage to treatment
for newly diagnosed individuals in
Panama. Additionally, key HIV
treatment activities will include linkage
to care registries, early treatment
initiation, differentiated service delivery
models, opportunistic infection
diagnosis and treatment, lost-to followup reengagement, quality assurance in
Viral Load (VL) networks, and drug
resistance monitoring.
MINSA is in a unique position to
conduct this work, as it is the sole
organization authorized to oversee the
regions and medical sanitary areas
covered by health institutions deemed
to be scattered and decentralized in
Panama. Since its creation in 1969,
MINSA has served to streamline
programs within these areas by setting
up satellite systems in which higher
ranking institutions are responsible for
coordinating collaboration between
medical-sanitary area officials, urban
doctors, and the general hospital staff of
these complex institutions.
Summary of the Award
Recipient: Ministerio de Salud de la
Repu´blica de Panama´ (MINSA).
Purpose of the Award: The purpose of
this award is to contribute to the
achievement of 95–95–95 targets in
Panama by introducing or scaling up
high-impact HIV prevention, testing,
linkage, and treatment models across
the continuum of care and strengthening
HIV laboratory and information systems.
Amount of Award: The approximate
year 1 funding amount will be
$10,000,000 in Federal Fiscal Year
(FFY) 2022 funds, subject to the
availability of funds. Fund amounts for
years 2–5 will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–02406 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0020]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Coal Workers’
Health Surveillance Program (CWHSP)
to the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on September 14, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary for the
proper performance of the functions of the
agency, including whether the information
will have practical utility;
(b) Evaluate the accuracy of the agencies
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and assumptions
used;
(c) Enhance the quality, utility, and clarity
of the information to be collected;
(d) Minimize the burden of the collection
of information on those who are to respond,
including, through the use of appropriate
automated, electronic, mechanical, or other
technological collection techniques or other
forms of information technology, e.g.,
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Page 6557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Ministerio de Salud de la Rep[uacute]blica de Panam[aacute] (MINSA)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $10,000,000 for Year 1 of funding to the
Ministerio de Salud de la Rep[uacute]blica de Panam[aacute]
{MINSA{time} . The award will contribute to the achievement of 95-95-95
targets (95% of HIV-positive individuals knowing their status, 95% of
those receiving ART [Antiretroviral therapy], and 95% of those
achieving viral suppression) in Panama by introducing or scaling up
high-impact HIV prevention, testing, linkage, and treatment models
across the continuum of care and strengthening HIV laboratory and
information systems. Funding amounts for years 2-5 will be set at
continuation.
DATES: The period for this award will be September 30, 2022 through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Lily de Leon, Center for Global
Health, Centers for Disease Control and Prevention, 18 Avenida 11-37,
Zona 15, VHIII, Telephone: 800-232-6348, Email: [email protected].
SUPPLEMENTARY INFORMATION: The single-source award will include key HIV
prevention and diagnosis activities: Index testing, differentiated
service modalities at key population testing facilities, self-testing,
Pre-Exposure Prophylaxis (PreP), rapid recency testing and response to
clusters of recent transmission, and linkage to treatment for newly
diagnosed individuals in Panama. Additionally, key HIV treatment
activities will include linkage to care registries, early treatment
initiation, differentiated service delivery models, opportunistic
infection diagnosis and treatment, lost-to follow-up reengagement,
quality assurance in Viral Load (VL) networks, and drug resistance
monitoring.
MINSA is in a unique position to conduct this work, as it is the
sole organization authorized to oversee the regions and medical
sanitary areas covered by health institutions deemed to be scattered
and decentralized in Panama. Since its creation in 1969, MINSA has
served to streamline programs within these areas by setting up
satellite systems in which higher ranking institutions are responsible
for coordinating collaboration between medical-sanitary area officials,
urban doctors, and the general hospital staff of these complex
institutions.
Summary of the Award
Recipient: Ministerio de Salud de la Rep[uacute]blica de
Panam[aacute] (MINSA).
Purpose of the Award: The purpose of this award is to contribute to
the achievement of 95-95-95 targets in Panama by introducing or scaling
up high-impact HIV prevention, testing, linkage, and treatment models
across the continuum of care and strengthening HIV laboratory and
information systems.
Amount of Award: The approximate year 1 funding amount will be
$10,000,000 in Federal Fiscal Year (FFY) 2022 funds, subject to the
availability of funds. Fund amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Period of Performance: September 30, 2022 through September 29,
2027.
Dated: February 1, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-02406 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
